Evidence map›Paper›PMID 37772122›Full record

ArticleChemical science2023

Dibenzannulated

Frédéric Lirette, Ali Darvish, Zheng Zhou, Zheng Wei, Lukas Renn, Marina A Petrukhina, R Thomas Weitz, Jean-François Morin

Abstract read
In one paragraph

Article in Chemical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Frédéric LiretteDépartement de chimie and Centre de Recherche sur les Matériaux Avancés (CERMA) 1045 Ave de la Médecine, Université Laval Québec G1V 0A6 Canada jean-francois.morin@chm.ulaval.ca.
Ali DarvishDépartement de chimie and Centre de Recherche sur les Matériaux Avancés (CERMA) 1045 Ave de la Médecine, Université Laval Québec G1V 0A6 Canada jean-francois.morin@chm.ulaval.ca.
Zheng ZhouDepartment of Chemistry, University at Albany, State University of New York 1400 Washington Avenue Albany New York 12222-0100 USA.ORCID https://orcid.org/0000-0001-8905-9663
Zheng WeiDepartment of Chemistry, University at Albany, State University of New York 1400 Washington Avenue Albany New York 12222-0100 USA.ORCID https://orcid.org/0000-0003-4782-021X
Lukas Renn1st Institute of Physics, Faculty of Physics, Georg-August-University Göttingen Germany.
Marina A PetrukhinaDepartment of Chemistry, University at Albany, State University of New York 1400 Washington Avenue Albany New York 12222-0100 USA.ORCID https://orcid.org/0000-0003-0221-7900
R Thomas Weitz1st Institute of Physics, Faculty of Physics, Georg-August-University Göttingen Germany.ORCID https://orcid.org/0000-0001-5404-7355
Jean-François MorinDépartement de chimie and Centre de Recherche sur les Matériaux Avancés (CERMA) 1045 Ave de la Médecine, Université Laval Québec G1V 0A6 Canada jean-francois.morin@chm.ulaval.ca.ORCID https://orcid.org/0000-0002-9259-9051

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of dibenzannulated phenyl-annulated [4,2]

Identifiers

PMID37772122
PMCPMC10530754

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.